Table 2.
Prognostic factors evaluated in the whole population according to the different outcomes.
| Relapse | Time to relapse | N. of relapses | Prevalence of FR-SD | PDN after remission | Relapse-free survival | Relapse-free survival adjusted (Holm's method) | |
|---|---|---|---|---|---|---|---|
| Whole population | |||||||
| Age at onset (years) | 0.00002 | 0.0006 | 0.0009 | 0.00005 | 0.046 | 0.0000001 | 0.000002 |
| TTR (days) | 0.088 | NS | NS | 0.003 | NS | NS | NS |
| Prednisone dose in induction (mg/m2) | NS | NS | NS | NS | NS | NS | NS |
| Hemoglobin (g/dL) | NS | NS | NS | NS | NS | NS | NS |
| Urea (mg/dL) | NS | NS | NS | NS | 0.005 | NS | NS |
| Creatinine (mg/dl) | 0.016 | NS | 0.012 | 0.042 | 0.017 | 0.0037 | 0.056 |
| Uricemia (mg/dL) | NS | NS | NS | 0.07 | NS | 0.096 | NS |
| Total proteins (g/dL) | 0.0003 | 0.009 | 0.005 | 0.019 | 0.00002 | 0.00001 | 0.00019 |
| Albumin (g/dL) | 0.058 | 0.004 | NS | 0.086 | 0.025 | 0.0009 | 0.0162 |
| Alpha 2 globulins (g/L) | NS | NS | NS | NS | NS | NS | NS |
| Gamma globulins (g/L) | NS | NS | NS | NS | NS | 0.068 | NS |
| Tot. cholesterol (mg/dL) | 0.049 | NS | NS | NS | 0.09 | NS | NS |
| Triglycerides (mg/dL) | 0.08 | NS | NS | 0.056 | NS | 0.059 | NS |
| Na (mmol/L) | 0.06 | 0.02 | NS | NS | 0.06 | 0.039 | NS |
| K (mmol/L) | NS | NS | NS | NS | NS | NS | NS |
| Ca (mg/dL) | NS | NS | NS | NS | 0.014 | NS | NS |
| P (mg/dL) | NS | NS | NS | NS | NS | NS | NS |
| uPr/uCr (mg/mg) | 0.039 | 0.016 | NS | 0.00016 | 0.026 | 0.001 | 0.017 |
| Proteinuria (g/L) | NS | 0.007 | 0.046 | 0.002 | 0.0006 | 0.001 | 0.017 |
| Microhematuria | NS | NS | NS | NS | NS | NS | NS |
p-values are in red if <0.05, in green if ≥0.05, and <0.10. All p > 0.10 are labeled as NS (not significant).